KeywiseAI
Founded 2019 · 5 employees on LinkedIn · 5 known investors
KeyWise AI develops Skye, a system that continuously assesses cognitive performance by passively capturing keystroke behavior (not content) as people type on their phones during normal use. Its validity is supported by NIH and NIA research funding and peer-reviewed university studies.
Also known as KeyWise · KeyWise AI · Skye
Investors · 5
Company profile
researched Aug 2026KeyWise AI develops Skye, a system that continuously assesses cognitive performance by capturing keystroke behavior — the patterns of how a person types — rather than the words they type. Data is gathered passively while a person uses their phone normally for emails, social media posts and text messages, so no quizzes, games or dedicated testing activities are required of the user. The company positions the product as a "fitness tracker for the brain," producing objective metrics for brain health.
The product consists of a personal AI keyboard that records typing patterns, algorithms that compute brain-health metrics from those patterns, personalized insights derived from changes in the metrics over time, and detection of behavioral factors that contribute to those metrics. The company states that typed words are neither captured nor saved and that it has no visibility into or access to typed content. User testimonials on the company site reference a daily "clarity score" and use of the app to communicate cognitive state to health professionals, friends and family.
▸Full profile — market position, technology, go-to-market
Market position
KeyWise AI cites validation of Skye through research funding from the National Institutes of Health and the National Institute on Aging, along with peer-reviewed studies conducted at the University of Illinois, UC San Diego, Rutgers and UT Dallas. The company also references media exposure, including an ESPN SportsCenter interview featuring KeyWise-sponsored student athlete Bella Rasmussen discussing her achievements and brain health.
Technology
Skye is built around a personal AI keyboard installed on a user's smartphone that passively collects keystroke behavior during ordinary typing. Algorithms described by the company as science-backed convert these typing patterns into objective cognitive-performance and brain-health metrics, which are tracked longitudinally to generate personalized insights and to identify behavioral contributors to metric changes. The company states that content — the actual words typed — is not captured or stored, and that it has no access to it. The underlying approach is described as based on years of federally funded scientific research.
Go-to-market
Individuals seeking objective measurement of their own cognitive performance and brain health; user testimonials on the company site come from adults in their twenties and thirties, including a cancer survivor, and reference sharing results with health professionals.
Compiled by commissioned research from 2 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsKeyWise published an ESPN SportsCenter interview with KeyWise-sponsored student athlete Bella Rasmussen discussing her achievements and brain health.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 2
primary sources listed
- KeywiseAIkeywise.tech · web
2 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does KeywiseAI do?
- KeyWise AI builds Skye, a smartphone keyboard system that measures cognitive performance from keystroke behavior rather than content.
- Who are KeywiseAI's investors?
- KeywiseAI's investors include 3CC | Third Culture Capital, Illinois Ventures, Joyance Partners, Merus Capital, Tribes Ventures.